Congenital mesoblastic nephroma 50 years after its recognition: A narrative review
Pediatric Blood & Cancer2017Vol. 64(7), pp. e26437–e26437
Citations Over TimeTop 10% of 2017 papers
Saskia L. Gooskens, Maite E. Houwing, Gordan Vujanić, Jeffrey S. Dome, T. Diertens, Aurore Coulomb L’Herminé, Jan Godziński, Kathy Pritchard‐Jones, Norbert Graf, Marry M. van den Heuvel‐Eibrink
Abstract
Congenital mesoblastic nephroma (CMN) is a rare pediatric renal tumor with low malignant potential that most commonly occurs early in infancy. Treatment strategies are based on the few published CMN series, while a significant number of CMN patients have been described in case reports. The aim of this narrative review was to create an up-to-date overview of the literature. Complete surgical removal is curative in most cases. The risk of treatment-related mortality (both surgery- and chemotherapy-related) is relatively high in the first weeks of life, indicating that these young patients deserve special attention with respect to timing and type of treatment.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)